Nano vaccine for hepatitis B shows promise for third world

August 13, 2008

Nanoemulsion could save more lives by removing current vaccines' drawbacks

ANN ARBOR, Mich. - Chronic hepatitis B infects 400 million people worldwide, many of them children. Even with three effective vaccines available, hepatitis B remains a stubborn, unrelenting health problem, especially in Africa and other developing areas. The disease and its complications cause an estimated 1 million deaths globally each year.

In many poor countries, refrigerated conditions required for the current vaccines are costly and hard to come by. It's often difficult in the field to keep needles and syringes sterile. The need to have people return for the three shots currently required also limits success.

Now, a new vaccine that avoids these drawbacks has moved a step closer to human trials. Health researchers hope it will make it possible to immunize large numbers of children and adults in Africa, Asia and South America efficiently and safely.

Scientists at the Michigan Nanotechnology Institute for Medicine and Biological Sciences at the University of Michigan report that a novel, needle-less method for getting an immunity-stimulating agent into the body has proved non-toxic and able to produce strong, sustained immune responses in animal studies. The vaccine is based on a super-fine emulsion of oil, water and surfactants placed in the nose.

The research was supported by the Grand Challenges in Global Health initiative, which is funded by the Bill & Melinda Gates Foundation, the Foundation for the National Institutes of Health, the Wellcome Trust and the Canadian Institutes of Health Research. The findings appear online in the journal PLoS ONE.

The nanoemulsion represents a new delivery method for an antigen already used in existing hepatitis B vaccines to activate the body's immune defenses.

"Our results indicate that needle-free nasal immunization, using a combination of nanoemulsion and hepatitis B antigen, could be a safe and effective hepatitis B vaccine, and also provide an alternative booster method for existing vaccines," says James R. Baker, Jr., M.D., the study's senior author and director of the institute. He also is Ruth Dow Doan Professor and allergy division chief in the U-M Department of Internal Medicine.

The nanoemulsion is made up of soybean oil, alcohol, water and detergents emulsified into droplets less than 400 nanometers in diameter.

The study suggests that the new type of hepatitis B vaccine will not have rigid cold storage requirements and could require fewer administrations than current vaccines, which require three shots given over a period of six months. Protective immunity with the new vaccine required only two immunizations in animals. The vaccine also avoids the risk of spreading needle-borne infections.

The nanoemulsion vaccine also avoids the temporary pain and redness that results after people get shots with the current vaccines, in which an irritating compound, alum, is used as an adjuvant, or enhancer of a vaccine's effect. There was no local inflammation at the nasal site of administration with the new vaccine.

This finding may be significant, because one of the major concerns for nasal administration of vaccines is that they can find their way to the olfactory bulb in the brain and cause side effects, says Paul E. Makidon, D.V.M., co-first author of the study and a U-M research fellow. "Our studies, however, indicate no inflammation and no evidence of the vaccine in the olfactory bulb," he says.

Baker's team has published earlier studies affirming the promise of nasal nanoemulsions as a strategy for smallpox, influenza, anthrax and HIV vaccines. The nanoemulsion technology is patented by U-M and licensed to Ann Arbor-based NanoBio Corporation. Baker is a founder and equity holder of NanoBio.

Research details:

The research team determined effective doses of the antigen and nanoemulsion. In results obtained in mice, rats and guinea pigs, the nanoemulsion vaccine proved effective at producing three types of immunity: systemic, mucosal and cellular. Further toxicity studies in rodents and dogs showed the vaccine was safe and well-tolerated.

The vaccine was as effective as current hepatitis B vaccines in eliciting systemic protective antibodies in the blood of animals. The nanoemulsion acted as an effective adjuvant, without the need for a traditional adjuvant or inflammatory compound as in the current hepatitis B vaccines.

In addition, the nanoemulsion vaccine produced sustained cellular immunity in Th1 cells, which could make the vaccine useful in treating people with chronic hepatitis B whose own cellular immune responses are inadequate.

The animals given the nasal nanoemulsion in the study also activated a third type of immunity, mucosal immunity, which is gaining recognition among immunologists as a key first-line response to infectious agents in diseases such as hepatitis B where mucosal tissues are involved in transmission. Baker and his team found the same effect of activating mucosal immunity that was seen in their previous studies of other nanoemulsion-based vaccines.

The researchers tested whether the vaccine could remain stable and effective even if not refrigerated. They found the nanoemulsion vaccine retained its effectiveness for six months when kept at 25 degrees Celsius (77 degrees Fahrenheit), and even was stable and effective for six weeks at 40 degrees C (104 degrees F). This suggests that refrigeration will not be needed for the final distribution of the vaccine in developing countries, making it easier to vaccinate underserved people.

Current studies are focused on developing the preclinical data required to enter human trials, Baker says. The researchers hope that the first human trial can begin within a year.

University of Michigan Health System

---

---

	Stable Nanoemulsions, Volume 25: Self-Assembly in Nature and Nanomedicine (Studies in Interface Science) by Joseph D'Arrigo (Author) Certain stable lipid nanoemulsions, existing in natural waters and certain artificial media, display - upon intravenous injection - a marked capability for rapid active targeting, both to tumors and to certain lesion sites. This category of lipid nanoemulsions contains no phospholipids, no proteins nor peptides, no carbohydrates, and no chemical modification of the lipophilic drugs is required; consequently it avoids various past problems reported for earlier versions of targeted nanoemulsions. The book covers in detail the underlying chemical and biochemical principles of stable lipid nanoemulsions as well as many current and potential applications in nanomedicine such as targeted chemotherapy. It is in harmony with goals of the current US National Nanotechnology Initiative, which...
	Three patents issued for NanoBio's antimicrobial nanoemulsion technology.(NanoBio Corporation, University of Michigan): An article from: BIOTECH Patent News by Biotech Patent News (Publisher) This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on February 1, 2004. The length of the article is 426 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Three patents issued for NanoBio's antimicrobial nanoemulsion technology.(NanoBio Corporation, University of Michigan) Publication: BIOTECH Patent News (Newsletter) Date: February 1, 2004 Publisher: Biotech Patent News Volume: 18 Issue: 2 Distributed by Thomson...
	Nutraceutical nanoemulsion encapsulates, delivers ginsenosides.: An article from: Emerging Food R&D Report by Gale Reference Team (Author) This digital document is an article from Emerging Food R&D Report, published by Food Technology Intelligence, Inc. on February 1, 2009. The length of the article is 358 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Nutraceutical nanoemulsion encapsulates, delivers ginsenosides. Author: Gale Reference Team Publication: Emerging Food R&D Report (Newsletter) Date: February 1, 2009 Publisher: Food Technology Intelligence, Inc. Volume: 19 Issue: 11 Page: NA Distributed by Gale, a part of Cengage...
	Cosmetic nanoemulsions by simple dilution with water.: An article from: Household & Personal Products Industry by Anna Howe (Author), Dana Adkins (Author), Juergen Meyer (Author), Gabriele Polak (Author) This digital document is an article from Household & Personal Products Industry, published by Rodman Publishing on April 1, 2009. The length of the article is 1782 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Cosmetic nanoemulsions by simple dilution with water. Author: Anna Howe Publication: Household & Personal Products Industry (Magazine/Journal) Date: April 1, 2009 Publisher: Rodman Publishing Volume: 46 Issue: 4 Page: S28(5) Distributed by Gale, a part of Cengage...
	Cosmetic nanoemulsions by simple dilution with water.: An article from: Nonwovens Industry by Anna Howe (Author), Dana Adkins (Author), Juergen Meyer (Author), Gabriele Polak (Author) This digital document is an article from Nonwovens Industry, published by Rodman Publishing on April 1, 2009. The length of the article is 1390 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Cosmetic nanoemulsions by simple dilution with water. Author: Anna Howe Publication: Nonwovens Industry (Magazine/Journal) Date: April 1, 2009 Publisher: Rodman Publishing Volume: 40 Issue: 4 Page: S28(5) Distributed by Gale, a part of Cengage...
	Nanoemulsion speeds herpes labialis healing.(INFECTIOUS DISEASES): An article from: Skin & Allergy News by Michael Kaufman (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on May 1, 2009. The length of the article is 673 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Nanoemulsion speeds herpes labialis healing.(INFECTIOUS DISEASES) Author: Michael Kaufman Publication: Skin & Allergy News (Magazine/Journal) Date: May 1, 2009 Publisher: International Medical News Group Volume: 40 Issue: 5 Page: 34(1) Distributed by Gale, a part of Cengage...
	FIRST CLEAR NANO-EMULSION DIESEL PLANT OPENS IN SINGAPORE.: An article from: Industrial Environment by Unavailable (Author) This digital document is an article from Industrial Environment, published by Worldwide Videotex on March 1, 2010. The length of the article is 745 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: FIRST CLEAR NANO-EMULSION DIESEL PLANT OPENS IN SINGAPORE. Author: Unavailable Publication: Industrial Environment (Newsletter) Date: March 1, 2010 Publisher: Worldwide Videotex Volume: 21 Issue: 3 Page: NA Distributed by Gale, a part of Cengage...
	Nanoemulsion beverage optimizes delivered concentrations of lutein.: An article from: Emerging Food R&D Report by Unavailable (Author) This digital document is an article from Emerging Food R&D Report, published by Food Technology Intelligence, Inc. on April 1, 2010. The length of the article is 378 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Nanoemulsion beverage optimizes delivered concentrations of lutein. Author: Unavailable Publication: Emerging Food R&D Report (Newsletter) Date: April 1, 2010 Publisher: Food Technology Intelligence, Inc. Volume: 21 Issue: 1 Page: NA Distributed by Gale, a part of Cengage...
	Nanoemulsions in Foods - Patent and Technology Report - Key players, innovators and industry analysis by Dolcera Corporation (Author)
	ENCAPSULATION OF NANO-EMULSIONS BY SPRAY DRYING: Optimization of the process by Seid Mahdi Jafari (Author) Microencapsulation is a rapidly expanding technology which is a unique way to package materials in the form of micro- and nanoparticles, and has been well developed and accepted within the pharmaceutical, chemical, food and many other industries. Spray drying is the most commonly used encapsulation technique for food products. A successful spray drying encapsulation relies on achieving high retention of the core materials especially volatiles and minimum amounts of the surface oil on the powder particles for both volatiles and non-volatiles during the process and storage. The properties of wall and core materials and the prepared emulsion along with the drying process conditions will influence the efficiency and retention of core compounds. This book highlights the new developments in...